Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion type Assertion NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_head.
- NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion description "[The ERCC2 genotype appears as an important predictive factor of the survival of patients treated with oxaliplatin in first-line therapy for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_provenance.
- NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion evidence source_evidence_literature NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_provenance.
- NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion SIO_000772 18085999 NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_provenance.
- NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion wasDerivedFrom lhgdn-20090331 NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_provenance.
- NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_assertion wasGeneratedBy ECO_0000203 NP169441.RA1qTernGFqgdJBLkBcRvdUHRB-JQimc7pS4ik_qw9nW0130_provenance.